Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 31

1.

Residual cardiovascular risk of lipid origin. Components and pathophysiological aspects.

Hernández-Mijares A, Ascaso JF, Blasco M, Brea Á, Díaz Á, Mantilla T, Pedro-Botet J, Pintó X, Millán J; Grupo de trabajo sobre Dislipidemia Aterogénica, Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2018 Sep 24. pii: S0214-9168(18)30085-8. doi: 10.1016/j.arteri.2018.06.007. [Epub ahead of print] English, Spanish.

PMID:
30262442
2.

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study.

Moreno G, Rodríguez A, Reyes LF, Gomez J, Sole-Violan J, Díaz E, Bodí M, Trefler S, Guardiola J, Yébenes JC, Soriano A, Garnacho-Montero J, Socias L, Del Valle Ortíz M, Correig E, Marín-Corral J, Vallverdú-Vidal M, Restrepo MI, Torres A, Martín-Loeches I; GETGAG Study Group.

Intensive Care Med. 2018 Sep;44(9):1470-1482. doi: 10.1007/s00134-018-5332-4. Epub 2018 Aug 3.

PMID:
30074052
3.

Fibrates in primary prevention of cardiovascular disease. Comments on the results of a systematic review of the Cochrane Collaboration.

Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X.

Clin Investig Arterioscler. 2018 Jul - Aug;30(4):188-192. doi: 10.1016/j.arteri.2018.04.002. Epub 2018 May 19. English, Spanish.

PMID:
29789212
4.

Fibrates in the secondary prevention of cardiovascular disease (infarction and stroke). Results of a systematic review and meta-analysis of the Cochrane collaboration.

Millan J, Pintó X, Brea A, Blasco M, Hernández-Mijares A, Ascaso J, Diaz A, Mantilla T, Pedro-Botet J.

Clin Investig Arterioscler. 2018 Jan - Feb;30(1):30-35. doi: 10.1016/j.arteri.2017.11.001. Epub 2018 Feb 1. Review. English, Spanish.

PMID:
29395493
5.

Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study).

Pérez de Isla L, Alonso R, Mata N, Fernández-Pérez C, Muñiz O, Díaz-Díaz JL, Saltijeral A, Fuentes-Jiménez F, de Andrés R, Zambón D, Piedecausa M, Cepeda JM, Mauri M, Galiana J, Brea Á, Sanchez Muñoz-Torrero JF, Padró T, Argueso R, Miramontes-González JP, Badimón L, Santos RD, Watts GF, Mata P.

Circulation. 2017 May 30;135(22):2133-2144. doi: 10.1161/CIRCULATIONAHA.116.024541. Epub 2017 Mar 8.

PMID:
28275165
6.

Consensus document on the management of the atherogenic dyslipidaemia of the Spanish Society of Arteriosclerosis.

Ascaso JF, Millán J, Hernández-Mijares A, Blasco M, Brea Á, Díaz Á, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica de la SEA.

Clin Investig Arterioscler. 2017 Mar - Apr;29(2):86-91. doi: 10.1016/j.arteri.2016.11.001. Epub 2017 Feb 6. English, Spanish.

PMID:
28185675
7.

Value of the Definition of Severe Familial Hypercholesterolemia for Stratification of Heterozygous Patients.

Pérez-Calahorra S, Sánchez-Hernández RM, Plana N, Marco-Benedi V, Pedro-Botet J, Almagro F, Brea A, Ascaso JF, Lahoz C, Civeira F; Dyslipidemia Registry of Spanish Arteriosclerosis Society.

Am J Cardiol. 2017 Mar 1;119(5):742-748. doi: 10.1016/j.amjcard.2016.11.025. Epub 2016 Dec 2.

PMID:
28081939
8.

Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome.

Álvarez-Lerma F, Marín-Corral J, Vila C, Masclans JR, González de Molina FJ, Martín Loeches I, Barbadillo S, Rodríguez A; H1N1 GETGAG/SEMICYUC Study Group.

Crit Care. 2016 Oct 23;20(1):337.

9.

Sialodochitis fibrinosa (kussmaul disease) report of 3 cases and literature review.

Flores RBJ, Brea AB, Sanabria SAA, Andrus RF, Espinosa MM, Ramos GC, Lerma VA, Merino AC, Pérez PJA, Bellas MC, Villa ALF, Andréu SJL, Jiménez PM, Godoy TH, Campos EJ, Sanz SJ, Barbadillo MC, Isasi Z, Mulero MJ.

Medicine (Baltimore). 2016 Oct;95(42):e5132. Review.

10.

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment. (I). Nonalcoholic fatty liver disease and its association with cardiovascular disease.

Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2017 May - Jun;29(3):141-148. doi: 10.1016/j.arteri.2016.06.003. Epub 2016 Sep 28. Review. English, Spanish.

PMID:
27692633
11.

Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease.

Brea Á, Pintó X, Ascaso JF, Blasco M, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Millán J, Pedro-Botet J; Grupo de trabajo sobre Dislipemia Aterogénica, Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2017 Jul - Aug;29(4):185-200. doi: 10.1016/j.arteri.2016.06.002. Epub 2016 Sep 28. Review. English, Spanish.

PMID:
27692632
12.

[The real measurement of non-HDL-cholesterol: Atherogenic cholesterol].

Millán J, Hernández-Mijares A, Ascaso JF, Blasco M, Brea A, Díaz Á, González-Santos P, Mantilla T, Pedro-Botet J, Pintó X; Grupo de trabajo sobre Dislipemia Aterogénica. Sociedad Española de Arteriosclerosis.

Clin Investig Arterioscler. 2016 Nov - Dec;28(6):265-270. doi: 10.1016/j.arteri.2016.05.002. Epub 2016 Sep 12. Spanish.

PMID:
27633523
13.

[Fibrates therapy: Rational use fenofibrate 2016. Executive summary].

Brea A, Millán J, Ascaso JF, Blasco M, Díaz A, González-Santos P, Hernández-Mijares A, Mantilla T, Pedro-Botet JC, Pintó X; en nombre del Foro de la Dislipemia Aterogénica.

Clin Investig Arterioscler. 2016 Nov - Dec;28(6):295-301. doi: 10.1016/j.arteri.2016.06.001. Epub 2016 Sep 5. Spanish.

PMID:
27609708
14.

Genetic Variants of LDLR and PCSK9 Associated with Variations in Response to Antihypercholesterolemic Effects of Armolipid Plus with Berberine.

De Castro-Orós I, Solà R, Valls RM, Brea A, Mozas P, Puzo J, Pocoví M.

PLoS One. 2016 Mar 25;11(3):e0150785. doi: 10.1371/journal.pone.0150785. eCollection 2016.

15.

Attainment of LDL-Cholesterol Treatment Goals in Patients With Familial Hypercholesterolemia: 5-Year SAFEHEART Registry Follow-Up.

Perez de Isla L, Alonso R, Watts GF, Mata N, Saltijeral Cerezo A, Muñiz O, Fuentes F, Diaz-Diaz JL, de Andrés R, Zambón D, Rubio-Marin P, Barba-Romero MA, Saenz P, Sanchez Muñoz-Torrero JF, Martinez-Faedo C, Miramontes-Gonzalez JP, Badimón L, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2016 Mar 22;67(11):1278-85. doi: 10.1016/j.jacc.2016.01.008.

16.

[Consensus for pharmacologic treatment of atherogenic dyslipidemia with statin-fenofibrate combined therapy].

Panel Europeo de Expertos. Versión Española del Grupo de trabajo sobre Dislipemia Aterogénica.

Clin Investig Arterioscler. 2016 Mar-Apr;28(2):87-93. doi: 10.1016/j.arteri.2015.12.001. Epub 2016 Jan 19. Spanish.

PMID:
26811267
17.

Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.

Fuentes F, Alcala-Diaz JF, Watts GF, Alonso R, Muñiz O, Díaz-Díaz JL, Mata N, Sanchez Muñoz-Torrero JF, Brea Á, Galiana J, Figueras R, Aguado R, Piedecausa M, Cepeda JM, Vidal JI, Rodríguez-Cantalejo F, López-Miranda J, Mata P; SAFEHEART Investigators.

Int J Cardiol. 2015 Dec 15;201:79-84. doi: 10.1016/j.ijcard.2015.07.107. Epub 2015 Aug 5.

PMID:
26296047
18.

Effects of poly-bioactive compounds on lipid profile and body weight in a moderately hypercholesterolemic population with low cardiovascular disease risk: a multicenter randomized trial.

Solà R, Valls RM, Puzo J, Calabuig JR, Brea A, Pedret A, Moriña D, Villar J, Millán J, Anguera A.

PLoS One. 2014 Aug 1;9(8):e101978. doi: 10.1371/journal.pone.0101978. eCollection 2014.

19.

Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation.

Alonso R, Andres E, Mata N, Fuentes-Jiménez F, Badimón L, López-Miranda J, Padró T, Muñiz O, Díaz-Díaz JL, Mauri M, Ordovás JM, Mata P; SAFEHEART Investigators.

J Am Coll Cardiol. 2014 May 20;63(19):1982-9. doi: 10.1016/j.jacc.2014.01.063. Epub 2014 Mar 13.

20.

[Decalogue of clinical recommendations on atherogenic dyslipidemia].

Pedro-Botet J, Millán J, Brea Á, Díaz Á, González-Santos P, Hernández-Mijares A, Mantilla T, Pintó X, Simó R.

Clin Investig Arterioscler. 2014 Jan-Feb;26(1):38-40. doi: 10.1016/j.arteri.2013.11.007. Epub 2013 Dec 21. Spanish. No abstract available.

PMID:
24365580

Supplemental Content

Loading ...
Support Center